این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
پنجشنبه 1 آبان 1404
Journal of Research in Medical Sciences
، جلد ۱۷، شماره ۷، صفحات ۰-۰
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
Cardioprotective role of insulin: Advantage analogues
چکیده انگلیسی مقاله
Normal 0 false false false EN-US X-NONE FA MicrosoftInternetExplorer4 Aim: Type II diabetes mellitus (DM) increases the risk of cardiovascular disease. Treatment with insulin substantially reduces C - reactive protein (CRP) because of its anti-atherosclerotic action. This study was designed to explore and compare the cardio protective role of regular human insulin (RHI), aspart and lispro insulin in type II DM. Materials and Methods: A randomized, open, parallel group, comparative clinical study was conducted on 90 patients of type II DM. After baseline clinical assessment and investigations, RHI was prescribed to 30 patients, aspart insulin to 30 patients and lispro insulin to another 30 patients for 12 weeks. The efficacy variables were change in blood pressure, glycemic control, lipid profile, serum potassium, high-sensitivity CRP (hsCRP) and UKPDS 10-year CHD risk scoring over 12 weeks. At the end of the study, the patients were followed up and changes in variables from baseline were analyzed by statistical tools. Results: Systolic blood pressure decreased significantly in aspart group (P = 0.008) whereas diastolic blood pressure was decreased significantly both in aspart (P < 0.001) and lispro group (P = 0.01). Fasting, postprandial blood glucose and HbA1c were decreased in all three groups significantly but change in aspart group was superior (P = 0.01). Triglyceride was significantly better controlled by lispro (P < 0.01) whereas aspart insulin was superior to decrease total cholesterol and LDL (P < 0.05). The extent of potassium loss was significantly more with RHI (P = 0.004) than others. CRP-lowering effect (P = 0.017) and decrease in UKPDS risk scoring (P = 0.019) in aspart and lispro group was superior to RHI group. Conclusion: Short acting insulin analogues, especially aspart insulin have been found to have a better cardio protective role than RHI in type II DM.
کلیدواژههای انگلیسی مقاله
نویسندگان مقاله
rituparna maiti | rituparna maiti
department of pharmacology,prathima institute of medical sciences, nagunur road, karimnagar, andhra pradesh, india
jyothirmai jaida | jyothirmai jaida
department of pharmacology,prathima institute of medical sciences, nagunur road, karimnagar, andhra pradesh, india
pulukuri جان israel leander | pulukuri john israel leander
department of general medicine, prathima institute of medical sciences, nagunur road, karimnagar, andhra pradesh, india
محمد irfanuddin | mohammed irfanuddin
department of pharmacology,prathima institute of medical sciences, nagunur road, karimnagar, andhra pradesh, india
ادریس احمد | idris ahmed
department of pharmacology,prathima institute of medical sciences, nagunur road, karimnagar, andhra pradesh, india
anuradha palani | anuradha palani
department of pharmacology,prathima institute of medical sciences, nagunur road, karimnagar, andhra pradesh, india
نشانی اینترنتی
http://jrms.mui.ac.ir/index.php/jrms/article/view/8509
فایل مقاله
فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
Original Articles
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات